Reading HOV? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HOV free→Reading HOV? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HOV free→NYSEConsumer DiscretionaryResidential ConstructionSnapshot 2026-06-12
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is neutral, and earnings quality is robust, cash backs up reported profits. Risk is elevated, and the sector backdrop is a headwind, with HOV trading below typical compared to sector peers. Peer multiples imply a price about 6% below where it trades (it looks expensive on this basis); the read is fair. If HOV cuts guidance on the next call, that could have a meaningful negative impact. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 5 valuation methods, at three horizons. Current price $120.72. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $121 HOV trades at 18× p/e, in line with its 16× p/e peer median. Our $114 fair value reflects that, medium confidence. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 6% near-term growth, ahead of our forecast of about -6%. This describes what's priced in, not a forecast of the move.
No fragility gates fired.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Consumer Discretionary names rated neutral grew net income 48% of the time over the next year (vs 64% for the rest of the cohort, n=3804).
Over the trailing year it converted 8.10x of net income into operating cash flow. Historically, Consumer Discretionary names rated robust grew net income 65% of the time over the next year (vs 49% for the rest of the cohort, n=2427).
Most sensitive to the broad stock market and long-term interest rates.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, Fed net liquidity.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $-1.66 → $-0.56 (+66.3% / 30d). 1 raised, 0 cut, 1 covering analysts.
0 upgrades, 0 downgrades / 30d. 0% of analysts rate Buy.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$178.
How much price usually moves either way.
On a bad day, this stock has moved -$566.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $3,973.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
risk label changed from 'high' to 'elevated'.
Risk changed. Risk rose to elevated. The sector backdrop remains a headwind. The earnings quality is robust. Recent financial performance is neutral. Valuation is fair, priced roughly in line with peers.
as of 2026-06-12
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
No named catalysts to watch right now. Check back after the next earnings report.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for HOV yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
No material events in the last 90 days.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
A side-by-side read on sector standing, valuation, and risk versus Homebuilding.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
HOV Hovnanian Enterprises, Inc. | Typical Show detailsSector percentile: 31 of 100 | full | elevated |
DHI D. R. Horton | Typical Show detailsSector percentile: 53 of 100 | fair | moderate |
PHM PulteGroup | Typical Show detailsSector percentile: 60 of 100 | inexpensive | moderate |
LEN Lennar | Below typical Show detailsSector percentile: 29 of 100 | inexpensive | moderate |
NVR NVR, Inc. | Typical Show detailsSector percentile: 43 of 100 | fair | moderate |
Not enough signal yet.
Not investment advice. As of 2026-06-12.
via XLY
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
No qualifying priorities for this snapshot. Check back after the next refresh.